ANN ARBOR, Mich., Oct. 16 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the release and immediate availability of Oncomine(TM) Research Premium Edition, a high-value product extension of Oncomine Research Edition for academic and non-profit researchers. Oncomine Research Premium Edition includes custom gene filters, integration with Ingenuity Pathway Analysis software and full support for Oncomine Concepts Map, including the ability to upload custom and proprietary concepts in a secure environment.
"Oncomine Research Premium Edition makes our most advanced features and commercial-level support available to academic researchers for the first time," said Compendia co-founder and CEO Dan Rhodes, Ph.D. "We recognize the importance of academic research to the success of Oncomine, and are glad to provide this valuable tool to the research community at an affordable price."
Oncomine Research Premium Edition is designed for laboratories engaged in advanced cancer genomics research and can be purchased in 2-user or 10-user packages for $5,000 and $10,000 respectively. Oncomine Research Edition remains unchanged and available under a free license for academic and nonprofit users. Detailed product information on both products can be found at http://www.compendiabio.com.
About Compendia Bioscience, Inc.
Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes.
Oncomine(TM) combines a rapidly growing compendium of 20,000+ cancer
transcriptome profiles with a sophis
|SOURCE Compendia Bioscience, Inc.|
Copyright©2007 PR Newswire.
All rights reserved